Welcome

Sign out Have a question? We're here to help

Copyright © 2019 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Altimmune Inc (ALT)

$1.72 0.07 (3.91%)

19:59 EST ALT Stock Quote Delayed 15 Minutes

Volume:

Previous Close $1.72

Market Cap 59.76M

PE Ratio -0.48

EPS -3.58

Volume (Avg. Vol.) 141,500

Day's Range 1.71 - 1.85

52-Week Range 1.51 - 5.94

Dividend & Yield N/A (N/A)

ALT Stock Predictions, Articles, and Altimmune Inc News

From InvestorPlace
From the Web

Altimmune News: ALT Stock Skyrockets on Positive Flu Vaccine Data

By William White, InvestorPlace Writer Mar 19, 2019

Altimmune news concerning the results from a Phase 2 extension study of the company's NasoVAX has ALT stock heading higher today.

Why Altimmune Stock Is Sliding Lower Today

By William White, InvestorPlace Writer Oct 8, 2018

Altimmune stock was falling hard Monday on news that the company is selling additional stock to investors in a new offering.

Why Altimmune Stock Is Skyrocketing Today

By Karl Utermohlen, InvestorPlace Writer Sep 19, 2018

Altimmune stock (ALT) soared more than 285% following successful clinical trial data of a medication and a reverse split of common shares.

75 Biggest Movers From Yesterday

From Benzinga Dec 6, 2019

Gainers Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) shares jumped 78.8% to close at $15.00 on Thursday after the company reported positive clinical readout for its lead asset...

The Daily Biotech Pulse: Endo's Cellulite Treatment Accepted For Review, Diffusion Pharma Reports Positive Glioblastoma Data

From Benzinga Nov 20, 2019

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Nov. 19) 89bio Inc (NASDAQ: ETNB...

Stocks That Hit 52-Week Lows On Tuesday

From Benzinga Nov 19, 2019

Tuesday morning, 197 companies reached new 52-week lows. Highlights: MPLX (NYSE: MPLX) was the largest, in terms of market cap, to set a new 52-week low. Atlantis Technology (OTC...

The Daily Biotech Pulse: Amarin Gets Unanimous Backing For Vascepa Expansion, BeiGene's Blood Cancer Drug Gets Approval

From Benzinga Nov 15, 2019

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Nov. 14) 10X Genomics Inc (NASDAQ...

Stocks That Hit 52-Week Lows On Thursday

From Benzinga Nov 14, 2019

On Thursday morning, 131 companies achieved new lows for the year. Interesting Facts: Rogers Communications (OTC: RCIAF) was the largest firm by market cap to set a new 52-week...

The Daily Biotech Pulse: Amarin Braces For Vascepa Adcom Verdict, Biotechs On A Fundraising Spree, Zosano Makes Progress With Migraine Drug Filing

From Benzinga Nov 14, 2019

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs Nov. 13.) Antares Pharma Inc (...

Navellier Ratings

Powered by Portfolio Grader

Total Grade

D

Sell